Moderna seeks full FDA vaccine approval

Moderna has applied for full approval from US authorities for its
Covid-19 vaccine.

It's the second drugmaker, after Pfizer, to seek a license that would
allow it to market the vaccine beyond the end of the emergency
pandemic period.

Nick Harper reports from Washington.

IN: "Moderna..."
OUT: SOC
DUR: 35 secs

GENERIC: http://www.fsnradionews.com/feeds/0601moderna-nh.mp3